超声辅助静脉曲张手术与1470nm激光腔内消融治疗大隐静脉功能不全1年结果相似:单中心前瞻性随机研究
单中心前瞻性随机研究比较超声辅助静脉曲张手术(UAVS)与1470nm激光腔内消融(EVLA)治疗大隐静脉功能不全,各40例。1年临床与影像学复发无显著差异;UAVS组术后8小时疼痛评分更高,EVLA组术后1周更高;静脉临床严重程度评分两组均改善且无差异。UAVS技术成功率高,可作为EVLA的替代选择。
要点
- UAVS与1470nm EVLA在1年临床及影像学复发无显著差异
- UAVS组术后8小时疼痛评分较高,EVLA组术后1周较高
- 两组静脉临床严重程度评分在6个月和1年均显著改善且无差异
核心结论
- UAVS技术成功率高,可作为1470nm激光EVLA的合适替代方案。
研究设计与样本
- 两组均接受1周标准化术后镇痛,评估疼痛评分、静脉临床严重程度评分及6个月和1年复发。
主要发现
- 1年时UAVS与EVLA的临床或影像学大隐静脉复发均无显著差异。
- 术后8小时平均疼痛评分UAVS组更高(3.7 ± 1.2 vs 2.9 ± 1.0;P = .03)。
- 术后1周疼痛评分EVLA组更高(1.8 ± 0.7 vs 1.4 ± 0.5;P = .01)。
- 6个月静脉临床严重程度评分UAVS组从9.2 ± 3.7改善至2.4 ± 1.4,EVLA组从9.3 ± 3.2改善至2.1 ± 0.8(P = .64)。
- 1年时相应评分分别为1.3 ± 0.7和1.4 ± 0.6(P = .21)。
临床怎么用
- 对于大隐静脉功能不全,UAVS可作为EVLA的替代术式,尤其适合开放手术场景。
- 需注意UAVS术后早期(8小时)疼痛较明显,而EVLA术后1周疼痛较明显。
局限性
- 单中心研究,样本量较小(每组40例)。
- 仅报告1年短期结果,缺乏长期随访数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Technical errors are the most common preventable cause of recurrence after high ligation and stripping procedures for the treatment of great saphenous vein incompetence. Ultrasound-assisted varicose vein surgery (UAVS) uses intraoperative ultrasound during high ligation and stripping to minimize such failures, although no data have been reported regarding its use during open surgery. The present study compared the short-term outcomes of UAVS and endovenous laser ablation (EVLA) with a 1470-nm laser. METHODS: The present prospective randomized study was conducted from January 2019 to December 2019. We compared 40 patients who had undergone UAVS under regional anesthesia with an equal number of patients who had undergone EVLA under tumescent anesthesia. Both groups received 1 week of standardized postoperative analgesia. The improvements in the pain score, venous clinical severity score, and recurrence at 6 months and 1 year were studied. RESULTS: No significant differences were found in either clinical or radiologic great saphenous vein recurrence after UAVS compared with EVLA at 1 year. The mean pain score at 8 hours after the procedure was higher in the UAVS group (3.7 ± 1.2 vs 2.9 ± 1.0; P = .03). At 1 week, the score was higher in the EVLA group (1.8 ± 0.7 vs 1.4 ± 0.5; P = .01). At 6 months, the venous clinical severity score had improved from 9.2 ± 3.7 to 2.4 ± 1.4 in the UAVS group and from 9.3 ± 3.2 to 2.1 ± 0.8 in the EVLA group (P = .64). At 1 year, the corresponding scores were 1.3 ± 0.7 and 1.4 ± 0.6 (P = .21). CONCLUSIONS: UAVS has high technical success, making it a suitable alternative to EVLA using a 1470-nm laser.
引用
- Rajendran S, Nair HR, Irshad K M, et al. Ultrasound-assisted varicose vein surgery and endovenous laser ablation using 1470-nm laser for treatment of great saphenous vein incompetence has similar outcomes at 1 year in a single-center prospective randomized study. J Vasc Surg Venous Lymphat Disord. 2021. PMID: 34438089. doi:10.1016/j.jvsv.2021.08.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。